In High-Stakes Meetings, 340B Stakeholders Push to Sway HHS’ Rebate Guidance Ahead of Release

More than a dozen stakeholder groups haver recently met with federal officials about HHS' highly-anticipated 340B rebate guidance.
In a flurry of meetings with federal officials, drug industry and provider groups are making a final push to influence [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Supreme Court Allows HHS Reorganization and Layoffs to Continue, Effect on 340B Oversight Unclear

The U.S. Supreme Court this week greenlit the Trump administration’s plans for massive layoffs and a reorganization at HHS—for now.
The U.S. Supreme Court this week greenlit the Trump administration’s plans for massive layoffs and a reorganization at the U.S. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Griffith Named U.S. House E&C Committee’s Health Subcommittee Chair, 340B Critic Harshbarger Elevated to Vice Chair

U.S. Rep. Morgan Griffith (R-Va.) will take over as chairman of the House E&C Health Subcommittee, while U.S. Rep Diana Harshbarger (R-Tenn.) will become the panel’s new vice chair.
A Virginia Republican is set to replace longtime 340B critic U.S. Rep. Earl “Buddy” Carter (R-Ga.) as the chair of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Five Drugmakers Exempt New States from 340B Contract Pharmacy Restrictions

AbbVie was among five drugmakers to announce new state exemptions to their 340B contract pharmacy restrictions in early July.
Five major drugmakers recently announced new contract pharmacy restriction exemptions for 340B covered entities located in South Dakota and other [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: Updates in Tennessee and Utah

Key briefs were filed in litigation on contract pharmacy access laws in Tennessee and Utah.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Providers Slam Newly Enacted GOP Budget Law Over Deep Medicaid Cuts

President Donald Trump on July 4 signed a reconciliation bill with controversial Medicaid cuts that providers strongly criticized.
Provider groups are sharply criticizing the newly enacted, GOP-backed budget reconciliation bill, warning that its more than $1 trillion in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Providers Condemn Reconciliation Bill’s Medicaid Cuts, Urge Lawmakers to Reject Ahead of Final House Vote

Hospital and health center advocates cautioned that the “One Big Beautiful Bill” would have devastating effects on providers—many of whom already struggle with financial uncertainty—and the Medicaid patients they serve.
Hospital and health care provider advocates this week once again urged federal lawmakers to reject a controversial GOP-backed reconciliation plan [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Rep. Buddy Carter to Step Down as House E&C Health Subcommittee Chair

U.S. Rep. Earl “Buddy” Carter (R-Ga.) announced Wednesday that he was stepping down as chairman of the House Energy & Commerce Committee’s Health Subcommittee.
The head of a key U.S. House subcommittee that oversees 340B drug pricing program policy issues is leaving the chairmanship [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drug Industry Takes Aim at 340B Program’s Growth in Pair of Op-Eds

PhRMA President and CEO Steve Ubl and Joe Grogan, a former Trump assistant and director of the White House’s Domestic Policy Council, took aim at the 340B program in a pair of recent op-eds.
The head of an influential drug industry trade group and a former Trump administration official recently called for federal 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Column: Setting the Record Straight on 340B Growth

Ted Slafsky, publisher and CEO of 340B Report, writes about HHS Secretary Robert F. Kennedy Jr.'s controversial views on the 340B program.
U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.’s eagerly anticipated first take on the 340B drug discount [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live